Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease

被引:22
作者
Aller, Rocio [2 ,3 ]
Perez Castrillon, Jose Luis [2 ]
Antonio de Luis, Daniel [1 ,2 ]
Conde, Rocio [2 ]
Izaola, Olatz [2 ]
Gonzalez Sagrado, Manuel [2 ]
Concepcion Velasco, Maria [2 ]
Alvarez, Tomas [2 ,3 ]
Pacheco, David [2 ]
机构
[1] Univ Valladolid, Sch Med, Inst Endocrinol & Nutr, Ctr Invest Endocrinol & Clin Nutr, Valladolid 47130, Spain
[2] Univ Valladolid, Hosp Rio Hortega, Unit Invest, Valladolid 47130, Spain
[3] Hosp Clin Univ, Valladolid, Spain
关键词
Adipose Tissue; Non Alcoholic Fatty Liver Disease; Obesity; Osteocalcin; ENDOCRINE REGULATION; ENERGY-METABOLISM; HEPATIC STEATOSIS; SERUM OSTEOCALCIN; BONE; STEATOHEPATITIS; GLUCOSE; DENSITY; WOMEN; MASS;
D O I
10.1016/S1665-2681(19)31587-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Osteocalcin is a hormone with a complex cross-talk between adipose tissue and the skeleton. The aim of the present study was to explore the relation of osteocalcin with histopathological changes of NALFD patients. Subjects. A population of 69 NAFLD patients was analyzed. A liver biopsy was realized. Weight, fat mass, body mass index, basal glucose, insulin, insulin resistance (HOMA), total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides and osteocalcin levels were measured. Results. Patients were divided in two groups by median osteocalcin value (11.34 ng/mL), group I (patients with the low values) and group II (patients with the high values). Only liver fibrosis frequencies were different between groups (group I: 22.9% vs group II: 9.4%; p < 0.05). Patients in group I had higher levels of glucose (115.6 +/- 28.1 mg/dL vs. 103.7 +/- 24.3 mg/dL; p < 0.04), HOMA (4.6 +/- 3.1 units vs. 3.6 +/- 1.8 units; p < 0.04), weight (102.9 +/- 32.4 kg vs. 85.9 +/- 16.8 kg; p = 0.002) and body mass index (38.3 +/- 11.4 kg/m(2) vs. 30.1 +/- 5.7 kg/m(2); p = 0.001)) than patients in group II. Osteocalcin was inverse correlated with glucose (r = -0.4; p = 0.002) and HOMA (r = -0.3:p = 0.01). Conclusion. Osteocalcin is associated with liver fibrosis. However, this association disappeared in a multivariate analysis, and HOMA remained as an independent factor.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 22 条
  • [1] Bondini Silvia, 2007, Clin Liver Dis, V11, P17
  • [2] Molecular mediators of hepatic steatosis and liver injury
    Browning, JD
    Horton, JD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) : 147 - 152
  • [3] Nonalcoholic steatohepatitis: Definition and pathology
    Brunt, EM
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (01) : 3 - 16
  • [4] Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice
    Ferron, Mathieu
    Hinoi, Eiichi
    Karsenty, Gerard
    Ducy, Patricia
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (13) : 5266 - 5270
  • [5] Bone mineral density and disorders of mineral metabolism in chronic liver disease
    George, Joe
    Ganesh, Hosahithlu K.
    Acharya, Shrikrishna
    Bandgar, Tushar R.
    Shivane, Vyankatesh
    Karvat, Anjana
    Bhatia, Shobna J.
    Shah, Samir
    Menon, Padmavathy S.
    Shah, Nalini
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (28) : 3516 - 3522
  • [6] Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus
    Gerdhem, P
    Isaksson, A
    Åkesson, K
    Obrant, KJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (12) : 1506 - 1512
  • [7] OSTEOCALCIN AND MATRIX GLA PROTEIN - VITAMIN K-DEPENDENT PROTEINS IN BONE
    HAUSCHKA, PV
    LIAN, JB
    COLE, DEC
    GUNDBERG, CM
    [J]. PHYSIOLOGICAL REVIEWS, 1989, 69 (03) : 990 - 1047
  • [8] Khosla S, 1996, J BONE MINER RES, V11, P857
  • [9] Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]
  • [10] Reciprocal regulation of bone and energy metabolism
    Lee, Na Kyung
    Karsenty, Gerard
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (05) : 161 - 166